These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 27301486

  • 1. Oral immunization of mice with engineered Lactobacillus gasseri NM713 strain expressing Streptococcus pyogenes M6 antigen.
    Mansour NM, Abdelaziz SA.
    Microbiol Immunol; 2016 Aug; 60(8):527-32. PubMed ID: 27301486
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Protective immunity induced by an intranasal multivalent vaccine comprising 10 Lactococcus lactis strains expressing highly prevalent M-protein antigens derived from Group A Streptococcus.
    Wozniak A, Scioscia N, García PC, Dale JB, Paillavil BA, Legarraga P, Salazar-Echegarai FJ, Bueno SM, Kalergis AM.
    Microbiol Immunol; 2018 Jun; 62(6):395-404. PubMed ID: 29704396
    [Abstract] [Full Text] [Related]

  • 5. Enhanced protection against Streptococcus pyogenes infection by intranasal vaccination with a dual antigen component M protein/SfbI lipid core peptide vaccine formulation.
    Olive C, Schulze K, Sun HK, Ebensen T, Horváth A, Toth I, Guzman CA.
    Vaccine; 2007 Feb 26; 25(10):1789-97. PubMed ID: 17229503
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus.
    Olive C, Ho MF, Dyer J, Lincoln D, Barozzi N, Toth I, Good MF.
    J Infect Dis; 2006 Jun 15; 193(12):1666-76. PubMed ID: 16703510
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Microbially synthesized modular virus-like particles and capsomeres displaying group A streptococcus hypervariable antigenic determinants.
    Chuan YP, Wibowo N, Connors NK, Wu Y, Hughes FK, Batzloff MR, Lua LH, Middelberg AP.
    Biotechnol Bioeng; 2014 Jun 15; 111(6):1062-70. PubMed ID: 24338691
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Protection of mice from group A streptococcal infection by intranasal immunisation with a peptide vaccine that contains a conserved M protein B cell epitope and lacks a T cell autoepitope.
    Olive C, Clair T, Yarwood P, Good MF.
    Vaccine; 2002 Jun 21; 20(21-22):2816-25. PubMed ID: 12034109
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vivo efficacy of a chimeric peptide derived from the conserved region of the M protein against group C and G streptococci.
    Nordström T, Malcolm J, Magor G, Good MF, Batzloff MR.
    Clin Vaccine Immunol; 2012 Dec 21; 19(12):1984-7. PubMed ID: 23081813
    [Abstract] [Full Text] [Related]

  • 17. The emm-type diversity does not always reflect the M protein genetic diversity--is there a case for designer vaccine against GAS.
    Smeesters PR, Dramaix M, Van Melderen L.
    Vaccine; 2010 Jan 22; 28(4):883-5. PubMed ID: 19963033
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of novel Streptococcus pyogenes vaccine candidates incorporating multiple conserved sequences from the C-repeat region of the M-protein.
    Bauer MJ, Georgousakis MM, Vu T, Henningham A, Hofmann A, Rettel M, Hafner LM, Sriprakash KS, McMillan DJ.
    Vaccine; 2012 Mar 09; 30(12):2197-205. PubMed ID: 22265945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.